Epstein-Barr virus (EBV) infects nine out of ten people worldwide at some point during their lifetimes. Infections in early childhood often cause no disease symptoms, but people infected during adolescence or young adulthood ...
Nov 2, 2011
0
0
Researchers at the University of Sussex have identified how differences in the genetic sequence of the two main strains of the cancer-associated Epstein-Barr virus (EBV) can alter the way the virus behaves when it infects ...
Jul 18, 2019
0
157
A new study from researchers at Queen Mary, University of London shows how a particular virus tricks the immune system into triggering inflammation and nerve cell damage in the brain, which is known to cause MS.
Jan 5, 2012
0
0
Infectious mononucleosis, or mono, sidelines high school athletes every year. Kids who play sports aren't more susceptible to the disease. Instead, adolescent competitors are at a greater risk for one of the illness's serious ...
Apr 5, 2019
0
6
Canada has one of the highest rates of multiple sclerosis (MS) in the world, with 250 out of every 100,000 people affected.
Apr 25, 2022
0
22
A protein molecule, "BINDI," has been built to trigger self-destruction of cancer cells infected with the Epstein-Barr virus.
Jun 19, 2014
0
0
Some 90 percent of people are exposed to the Epstein Barr virus (EBV) at some point in their life. Even though it is quickly cleared from the body, the virus can linger silently for years in small numbers of infected B cells. ...
Feb 17, 2012
1
0
In a discovery that could hasten treatment for patients with multiple sclerosis (MS), UC San Francisco scientists have discovered a harbinger in the blood of some people who later went on to develop the disease.
Apr 19, 2024
0
111
In 1963, Irish surgeon Denis Parson Burkitt airmailed samples of an unusual jaw tumor found in Ugandan children to his colleague, Anthony Epstein, at Middlesex Hospital in London. Epstein, an expert in chicken viruses and ...
Aug 26, 2016
0
3
Age, sex, and specific human genetic variants are the key factors behind differences between immune responses among healthy humans, finds a study of 1,000 individuals carried out by EPFL and the Pasteur Institute.
Aug 6, 2018
0
23
